organophosphonates has been researched along with bradykinin in 3 studies
Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
---|---|---|---|---|---|
9,968 | 880 | 3,596 | 14,195 | 355 | 1,520 |
Protein | Taxonomy | organophosphonates (IC50) | bradykinin (IC50) |
---|---|---|---|
B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chappell, MC; Ferrario, CM; Iyer, SN | 1 |
Ahn, K; Fahnoe, DC; Johnson, GD; Knapp, J | 1 |
Chou, SH; Feske, SK; Hanchapola, I; Kuruppu, S; Lo, EH; Ning, M; Smith, AI; Suh, S | 1 |
3 other study(ies) available for organophosphonates and bradykinin
Article | Year |
---|---|
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1998 |
Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH.
Topics: Aspartic Acid Endopeptidases; Bradykinin; Endothelin-Converting Enzymes; Humans; Hydrogen-Ion Concentration; Metalloendopeptidases; Organophosphonates; Protease Inhibitors; Quinazolines; Substance P; Substrate Specificity; Tetrazoles | 2000 |
Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients.
Topics: Aspartic Acid Endopeptidases; Benzofurans; Bradykinin; Endothelin-1; Endothelin-Converting Enzymes; Enzyme Inhibitors; Humans; Hydrocephalus; Mass Spectrometry; Metalloendopeptidases; Organophosphonates; Subarachnoid Hemorrhage | 2014 |